Stock 600789 SHANDONG LUKANG PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shandong Lukang Pharmaceutical Co.,Ltd.

Equities

600789

CNE000000P61

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
9.75 CNY +0.93% Intraday chart for Shandong Lukang Pharmaceutical Co.,Ltd. +24.05% +36.55%
04-23 Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-22 Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Shandong Lukang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The Company's primary products include pharmaceutical preparation products, semi-synthetic antibiotic raw materials, veterinary antibiotics and antibiotic raw materials and others. The Company is also involved in the production and distribution of pharmaceutical intermediates. The Company distributes its products in domestic and overseas markets.

Number of employees: 6,484

Sales per Business

CNY in Million2022Weight2023Weight Delta
Veterinary Antibiotics
42.1 %
2,308 41.1 % 2,585 42.1 % +11.99%
Pharmaceutical Preparations
37.8 %
1,921 34.2 % 2,326 37.8 % +21.05%
Semi-synthetic Antibiotic API
11.3 %
785 14.0 % 693 11.3 % -11.65%
Other
4.3 %
275 4.9 % 264 4.3 % -3.98%
Antibiotic API
3.2 %
256 4.6 % 199 3.2 % -22.14%
Other Business
1.3 %
77 1.4 % 80 1.3 % +4.25%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
87.1 %
4,778 86.2 % 5,287 87.1 % +10.66%
International
12.9 %
767 13.8 % 780 12.9 % +1.72%

Managers

Managers TitleAgeSince
Kun Dong CEO
 Chief Executive Officer 55 21-05-18
Li Li DFI
 Director of Finance/CFO 58 16-02-29
Xin Peng CHM
 Chairman 51 94-07-31
Jie Zhang BRD
 Director/Board Member 57 03-07-31
Qiang Ming Bao IRC
 Investor Relations Contact - -
Li Xin Tian SEC
 Corporate Secretary 57 00-12-31

Members of the board

Members of the board TitleAgeSince
Hao Dong Qi BRD
 Director/Board Member 64 21-05-18
Zi Xin Deng BRD
 Director/Board Member 67 21-05-18
Xin Peng CHM
 Chairman 51 94-07-31
Li Li DFI
 Director of Finance/CFO 58 16-02-29
Jie Zhang BRD
 Director/Board Member 57 03-07-31
Ke Chun Cong BRD
 Director/Board Member 60 09-03-31
Cheng Tong Liu BRD
 Director/Board Member 53 14-05-31
Shuai Yang BRD
 Director/Board Member 50 13-04-17
Zhiyong Yang CHM
 Chairman 48 18-05-15
Tao Zhang BRD
 Director/Board Member 37 21-05-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 896,055,624 656,370,473 ( 73.25 %) 0 73.25 %

Shareholders

NameEquities%Valuation
Wanjia Asset Management Co., Ltd.
1.275 %
11,334,619 1.275 % 11 M ¥
Fullgoal Fund Management Co., Ltd.
0.5084 %
4,519,377 0.5084 % 4 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.2320 %
2,062,600 0.2320 % 2 M ¥
China Asset Management Co., Ltd.
0.1332 %
1,184,400 0.1332 % 1 M ¥
China Southern Asset Management Co., Ltd.
0.1165 %
1,035,330 0.1165 % 1 M ¥
Xin Peng
0.0648 %
576,200 0.0648 % 568 122 ¥
GF Fund Management Co., Ltd.
0.0579 %
514,900 0.0579 % 507 681 ¥
Gfund Management Co., Ltd.
0.0545 %
484,200 0.0545 % 477 412 ¥
Bosera Asset Management Co., Ltd.
0.0484 %
430,000 0.0484 % 423 971 ¥
Li Li
0.0353 %
313,800 0.0353 % 309 401 ¥

Company contact information

Shandong Lukang Pharmaceutical Co., Ltd.

No. 88, Deyuan Road High-tech Zone

272000, Jining

+86 53 7298 5865

http://www.lkpc.com
address Shandong Lukang Pharmaceutical Co.,Ltd.(600789)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANDONG LUKANG PHARMACEUTICAL CO.,LTD. Stock Shandong Lukang Pharmaceutical Co.,Ltd.
+36.55% 1.2B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 326B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 200B
AMGEN INC. Stock Amgen Inc.
+10.77% 167B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600789 Stock
  4. Company Shandong Lukang Pharmaceutical Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW